| Health / Medical Topics |
Antiangiogenic Drug Combination TL-118
A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal anti-inflammatory agent, an alkylating agent, a histamine H2 antagonist and a sulfonamide with potential anti-angiogenic and antineoplastic activities. Antiangiogenic drug combination TL-118 is administrated as a specific dosing regimen and may result in a synergistic effect and reduce angiogenesis and inhibit tumor cell proliferation. (NCI Thesaurus)
YOU MAY ALSO LIKE
Having to do with reducing the growth of new blood vessels.
A therapeutic regimen that uses synthetic compounds or natural substances to prevent the development of new blood vessels.
A drug or substance that keeps new blood vessels from forming. In cancer treatment, antiangiogenesis agents may prevent the growth of new…
Prevention of the growth of new blood vessels.
Treatment with drugs used to block production or interfere with the action of male sex hormones.
A substance that keeps androgens (male hormones) from binding to proteins called androgen receptors, which can be found in prostate cells and…
